COLLEGIUM PHARMACEUTIC
34.71
07-November-24 14:59:54
15 minutes delayed
Stocks
+0.21
+0.61%
Today's range
34.34 - 35.62
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
18 Dec 2023 11:28:44 By NetDania Notify
-
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
27 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
09 Nov 2023 07:00:01 By Nasdaq GlobeNewswire
-
Collegium to Participate in Upcoming Investor Conferences
08 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Reports Third Quarter 2023 Financial Results
07 Nov 2023 15:01:01 By Nasdaq GlobeNewswire
-
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
24 Oct 2023 07:00:01 By Nasdaq GlobeNewswire
-
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
28 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
24 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces $50 Million Accelerated Share Repurchase Program
07 Aug 2023 06:30:00 By Nasdaq GlobeNewswire
-
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
03 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
20 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
Collegium to Participate in Jefferies Healthcare Conference
01 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Collegium Reports First Quarter 2023 Financial Results
04 May 2023 15:01:00 By Nasdaq GlobeNewswire
-
Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
20 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 07:00:02 By Nasdaq GlobeNewswire
-
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
23 Feb 2023 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
22 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
07 Feb 2023 20:54:36 By Nasdaq GlobeNewswire
-
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
06 Feb 2023 15:08:00 By Nasdaq GlobeNewswire
-
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
06 Feb 2023 15:07:00 By Nasdaq GlobeNewswire